Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - irinotecan - irinotecan

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - irinotecanum - dispersion à diluer pour perfusion - irinotecanum 43 mg ut irinotecani sucrosofas corresp. irinotecani hydrochloridum trihydricum 50 mg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, n-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, acidum hydroxyethylpiperazinethansulfonicum, natrii chloridum corresp. natrium 33.1 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml. - adenocarcinomi del pancreas metastatico - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - erlotinibum - compresse rivestite con film - erlotinibum 25 mg ut erlotinibi hydrochloridum, lactosum monohydricum 23.98 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici copolymerum a, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 0.2 mg. - onkologikum - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - erlotinibum - compresse rivestite con film - erlotinibum 100 mg ut erlotinibi hydrochloridum, lactosum monohydricum 95.93 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici copolymerum a, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 0.7 mg. - onkologikum - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - erlotinibum - compresse rivestite con film - erlotinibum 150 mg ut erlotinibi hydrochloridum, lactosum monohydricum 143.9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici copolymerum a, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 1.1 mg. - onkologikum - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - erlotinibum - compresse rivestite con film - erlotinibum 25 mg a erlotinibi hydrochloridum 27.32 mg, lactosum monohydricum 27.43 mg, cellulosum microcristallinum, carboxymethylamylum natricum una e natrii laurilsulfas corrisp. di sodio 2 mg, magnesio stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 400, e 171, compresso haze. - farmaco - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - erlotinibum - compresse rivestite con film - erlotinibum 100 mg a erlotinibi hydrochloridum 109.29 mg, lactosum monohydricum 69.21 mg, cellulosum microcristallinum, carboxymethylamylum natricum una e natrii laurilsulfas corrisp. sodio 6 mg, magnesio stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 400, e 171, compresso haze. - farmaco - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - erlotinibum - compresse rivestite con film - erlotinibum 150 mg per erlotinibi hydrochloridum 163.93 mg, lactosum monohydricum 103.82 mg, cellulosum microcristallinum, carboxymethylamylum natricum una e natrii laurilsulfas corrisp. di sodio 9 mg, magnesio stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 400, e 171, compresso haze. - farmaco - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - capsule rigide - clindamycinum 150 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 224.13 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - malattie infettive - synthetika